Patents Assigned to Arisaph Pharmaceuticals, Inc.
  • Niacin mimetics, and methods of use thereof
    Patent number: 9212142
    Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: December 15, 2015
    Assignees: Trustees of Tufts College, Arisaph Pharmaceuticals, Inc.
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel P. O'Connell, Wengen Wu, Christopher P. Kiritsy
  • Niacin mimetics, and methods of use thereof
    Patent number: 8937063
    Abstract: Disclosed are heterocyclylalkyl-substituted and heteroaralkyl-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: January 20, 2015
    Assignees: Trustees of Tufts College, Arisaph Pharmaceuticals, Inc.
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel P. O'Connell, Wengen Wu, Christopher P. Kiritsy
  • Niacin mimetics, and methods of use thereof
    Patent number: 8450316
    Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: May 28, 2013
    Assignees: Trustees of Tufts College, Arisaph Pharmaceuticals, Inc.
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel Philip O'Connell, Wengen Wu, Christopher P. Kiritsy